Developer docs
API playgroundTry for free, no card

Search company profiles

Qingdao Haier Biomedical

Full company profile

uuid003grtr

Namestring
Qingdao Haier Biomedical
Legal namestring
青岛海尔生物医疗股份有限公司
Company typeenum
Public
Founded yearint
2005
Descriptiontext

Qingdao Haier Biomedical Co., Ltd. (青岛海尔生物医疗股份有限公司, SSE: 688139) is a publicly listed Chinese life science and medical equipment company founded in 2005 and headquartered in Qingdao, operating as a subsidiary of the Haier Group conglomerate. The company designs, manufactures, and sells ultra-low temperature storage systems, automated biobank solutions, IoT-enabled cold chain management equipment, biosafety products, and laboratory automation tools. Its core technology stack combines ultra-low temperature refrigeration, IoT connectivity, AI-powered monitoring and computer vision, and domain-specific AI models such as the Hailinglong Lingyan large language model — China's first sample-library domain-specific LLM. The company serves five primary verticals — universities/research institutes, hospitals, pharmaceutical companies, blood/plasma stations, and public health agencies — through direct enterprise sales, a global network of over 800 dealers across 160 countries, and overseas R&D centers in the UK, Italy, and Japan supporting localized product development.

The company's revenue model is anchored in hardware sales of life science laboratory equipment, complemented by an expanding AI-powered applications and solutions revenue stream (15% of 2025 revenue, up 2.5 percentage points from 2024). Full-year 2025 revenue reached 2.33 billion yuan (USD 340.77 million), a 17.9% year-over-year increase, with international revenue at 840 million yuan representing a record 36% of total. New business segments contributed 48.5% of total revenue, signaling successful business mix evolution from legacy cold chain hardware to integrated life science scenarios. The company is executing a three-year '543' strategic plan targeting over 50% overseas revenue, 30% AI-related revenue, and over 40% revenue from acquired businesses by 2028, supported by active geographic expansion (Q1 2026 growth of 50%+ in Germany, Australia, and Canada and over 100% in Eastern Europe, South Asia, and Brazil), ongoing product launches (HAB80-60KA/60KB, DWL368BPST, Super Energy series, AutoLab Mind, Hailinglong Lingyan LLM), and inorganic moves including the December 2023 acquisition of Guangzhou Kangsheng Biotechnology and EU MDR certification for the Plasma Apheresis System XJ-III.

Short descriptiontext

Qingdao Haier Biomedical (SSE: 688139) designs and sells ultra-low temperature storage systems, automated biobank solutions, IoT-enabled cold chain equipment, and AI-integrated life science laboratory products. The company serves pharmaceutical companies, hospitals, research institutes, biobanks, and public health agencies across 160 countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersQingdao, China
HQ citystring
Qingdao
HQ countrystring
China
HQ regionstring
Asia
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biomedical cold storage, ultra-low temperature freezers, automated biobank systems, IoT cold chain monitoring, life science laboratory equipment
Industry2 codes
PRIMARYHLAGAIAJ
Sample Preparation, Storage & Cryogenics (Freezers, Cryovials, Cryostats)
SECONDARYHLAGAMAG
Cold Chain Monitoring, Sensors & Control Towers (IoT, data loggers)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Supply Chain, Logistics & Cold Chain for Life Sciences
NAICS code4 codes
  • Air-Conditioning and Warm Air Heating Equipment and Commercial and Industrial Refrigeration Equipment Manufacturing333415
  • Medical Equipment and Supplies Manufacturing3391
  • Analytical Laboratory Instrument Manufacturing334516
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing3345
SIC code3 codes
  • Air-Cond & Warm Air Heatg Equip & Comm & Indl Refrig Equip3585
  • Refrigeration & Service Industry Machinery3580
  • Surgical & Medical Instruments & Apparatus3841
Product category
Life Science Laboratory Equipment
No data
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Life Science Laboratory Equipment Sales
TypeHardware Sales
Description

Haier Biomedical generates revenue primarily through the sale of life science laboratory equipment including ultra-low temperature freezers, automated sample storage systems, biobank solutions, blood management systems, and pharmaceutical storage solutions. The company achieved full-year 2025 revenue of 2.33 billion yuan (USD 340.77 million) with international revenue of 840 million yuan representing 36% of total revenue.

prnewswire.com
2AI-Powered Applications and Solutions
TypeSubscription Recurring
Description

AI-powered applications and software solutions contributed 15% of total revenue in 2025, up 2.5 percentage points from 2024, including automated biobank management, intelligent blood management, and AI-integrated medical products. New business segments contributed 48.5% of total revenue.

prnewswire.com
3Sustainability and Digital Transformation Services
TypeManaged Services
Description

The company provides digital, global, and platform-oriented transformation services aligned with its LIFE sustainability framework, positioning itself as an integrated life science tools and intelligent productivity platform provider rather than a pure hardware vendor.

prnewswire.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Operations, Personnel, Supply Chain, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1盈康一生 (Yingkang Yisheng)
Description

Related brand/platform under the Haier healthcare ecosystem umbrella.

haierbiomedical.com
Core offering1 text field

Qingdao Haier Biomedical designs, manufactures, and sells ultra-low temperature storage systems, automated biobank solutions, smart hospital medication and blood management systems, and AI-integrated medical products for pharmaceutical companies, research institutions, hospitals, blood stations, and public health agencies. The company also provides reagents, consumables, biosafety equipment, scientific instruments, and digital transformation services, and is transitioning from hardware supplier to integrated life science tools and intelligent productivity platform provider through its IoT and AI capabilities.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • 26% lower energy consumption and 45% faster temperature recovery compared to conventional models for DWL368BPST ultra-low temperature freezer
+6 more records
Product overview1 text field

Qingdao Haier Biomedical (海尔生物医疗, stock code 688139.SH) is a life science and medical innovation company offering a comprehensive platform-plus-modules product architecture. The portfolio centers on ultra-low temperature storage systems (HAB80-60KA/60KB automated storage, DWL368BPST compact freezer, Ultra Energy series, Super Energy series) complemented by an extensive ecosystem of laboratory equipment including pre-processing systems, biosafety equipment, scientific instruments, and smart hospital solutions. The company is undergoing strategic transformation from hardware supplier to integrated life science tools provider, with AI+ capabilities now integrated across product lines through solutions like the Hailinglong Lingyan Large Model (sample library AI), AutoLab Mind platform, AI+ automated cell culture solutions, cytotoxic drug dispensing robots, and intelligent blood management systems. Core solutions span biobank management, smart vaccination, digital hospital medication management, and laboratory automation.

Product and service4 records
1HAB80-60KA/60KB Automated Ultra-Low Temperature Sample Storage System
CategoryUltra-low temperature storage equipment
Description

Automated ultra-low temperature sample storage system for biobank applications at -80°C, with AI-powered monitoring, scalable modular architecture for 50,000 to 200,000+ samples, and low-carbon design targeting European biobank customers.

2DWL368BPST Compact Ultra-Low Temperature Freezer
CategoryUltra-low temperature storage equipment
Description

Space-efficient ultra-low temperature freezer engineered for Japanese laboratories, featuring 26% lower energy consumption, ±2°C temperature uniformity, and 45% faster temperature recovery compared to conventional models.

3Plasma Apheresis System XJ-III
CategoryBlood processing equipment
Description

Plasma apheresis system with EU MDR certification for blood component collection and processing in clinical settings across the European Union.

4Hailer Vaccine Smart Safety Solution (海乐苗智慧安全接种)
Scale indicator16 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-25
Description

Deep academic partnership with Università degli Studi di Padova as part of Haier Biomedical's strategy to deepen localization investments and build academic partnerships supporting the 'In Europe, for Europe' localization strategy and European market development.

2Alibaba Cloud (阿里云)
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-04-10
Description

AI for Science strategic ecosystem partnership for cloud computing and AI infrastructure support, announced at the 93rd CMEF as part of Haier Biomedical's AI+ innovation strategy ecosystem co-creation.

prnewswire.com
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-04-10
Description

AI for Science strategic ecosystem partnership for AI model development, announced at the 93rd CMEF as part of Haier Biomedical's AI+ innovation strategy ecosystem co-creation.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-04-10
Description

AI for Science strategic ecosystem partnership for robotics integration, announced at the 93rd CMEF as part of Haier Biomedical's AI+ innovation strategy ecosystem co-creation.

5Shandong University of Science and Technology (山东科技大学)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-10
Description

AI for Science strategic ecosystem partnership for research collaboration and talent development, announced at the 93rd CMEF as part of Haier Biomedical's AI+ innovation strategy ecosystem co-creation.

prnewswire.com
6China Information Industry Association Embodied AI Specialized Committee (中国信息协会具身智能专委会)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-10
Description

AI for Science strategic ecosystem partnership for embodied AI standards and industry collaboration, announced at the 93rd CMEF as part of Haier Biomedical's AI+ innovation strategy ecosystem co-creation.

prnewswire.com
737 European Regional Partners (23 Countries)
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-03-11
Description

European Partner Summit in Rome with 37 regional partners from 23 European countries, outlining the long-term European commitment and unveiling expanded laboratory solutions portfolio under the 'In Europe, for Europe' localization strategy. Rollout of automated biobank solutions and intelligent blood management systems through these channel partners.

morningstar.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

Partnership with GAVI for global immunization support and health equity, documented in the 2025 sustainability report under the LIFE framework aligned with UN's 17 Sustainable Development Goals. Includes charitable donations of 1.406 million yuan.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

US-based manufacturer of medical-grade cold storage, particularly blood bank refrigerators and plasma freezers. Direct overlap with Haier Biomedical's hospital, blood station, and clinical laboratory segments in North America.

TypeRegional player
Description

US-based manufacturer of laboratory equipment including biosafety cabinets and cold storage. Has partial product overlap with Haier Biomedical's biosafety and laboratory equipment lines, primarily in the North American market.

TypeDirect peer
Description

Direct competitor in biomedical cold storage, including ultra-low temperature freezers and pharmaceutical-grade refrigeration under PHCbi. Operates globally with strong European and US presence, making it a primary head-to-head rival for Haier Biomedical's ULT and biobank systems.

TypeBroad incumbent
Description

Global leader in life sciences with a deep portfolio including ultra-low temperature freezers, sample storage, and biobank solutions. Competes with Haier Biomedical across pharma and research customers worldwide but at vastly greater scale and with broader adjacent offerings.

TypeDirect peer
Description

US manufacturer of ultra-low temperature freezers with a focus on energy-efficient Stirling engine technology. Competes directly in the ULT freezer category, including for biobank and pharmaceutical storage applications.

TypeDirect peer
Description

Provider of sample storage, automated biobanking, and cold chain solutions. Recently combined with B Medical Systems, making it a direct competitor in automated sample management and biorepository solutions where Haier Biomedical's HAB80-60KA/60KB platform competes.

7Haier Smart Home
TypeOthers
Description

Sister listed entity under the same Haier Group parent, focused on consumer appliances. While not a direct competitor, it provides relevant peer context on the parent conglomerate's global brand and distribution scale leveraged by Haier Biomedical.

TypeDirect peer
Description

German lab equipment manufacturer with overlapping product lines in temperature-controlled storage, sample handling, and cell culture. Strong in European pharmaceutical and academic research markets where Haier Biomedical is actively expanding.

TypeBroad incumbent
Description

Shenzhen-based Chinese medical device major with extensive hospital and IVD product lines. Competes with Haier Biomedical in the smart hospital medication management and biomedical equipment segments within China and emerging markets.

TypeDirect peer
Description

Specializes in medical cold chain including vaccine cold boxes, plasma freezers, and ULT storage. Recently combined with Azenta's life sciences business, directly competing with Haier Biomedical in blood bank, vaccine, and biobank cold chain.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers13 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries5 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Qingdao Haier Biomedical

Life Science Laboratory Equipmenthaierbiomedical.com

Qingdao Haier Biomedical (SSE: 688139) designs and sells ultra-low temperature storage systems, automated biobank solutions, IoT-enabled cold chain equipment, and AI-integrated life science laboratory products. The company serves pharmaceutical companies, hospitals, research institutes, biobanks, and public health agencies across 160 countries.

What Qingdao Haier Biomedical does

Qingdao Haier Biomedical Co., Ltd. (青岛海尔生物医疗股份有限公司, SSE: 688139) is a publicly listed Chinese life science and medical equipment company founded in 2005 and headquartered in Qingdao, operating as a subsidiary of the Haier Group conglomerate. The company designs, manufactures, and sells ultra-low temperature storage systems, automated biobank solutions, IoT-enabled cold chain management equipment, biosafety products, and laboratory automation tools. Its core technology stack combines ultra-low temperature refrigeration, IoT connectivity, AI-powered monitoring and computer vision, and domain-specific AI models such as the Hailinglong Lingyan large language model — China's first sample-library domain-specific LLM. The company serves five primary verticals — universities/research institutes, hospitals, pharmaceutical companies, blood/plasma stations, and public health agencies — through direct enterprise sales, a global network of over 800 dealers across 160 countries, and overseas R&D centers in the UK, Italy, and Japan supporting localized product development.

The company's revenue model is anchored in hardware sales of life science laboratory equipment, complemented by an expanding AI-powered applications and solutions revenue stream (15% of 2025 revenue, up 2.5 percentage points from 2024). Full-year 2025 revenue reached 2.33 billion yuan (USD 340.77 million), a 17.9% year-over-year increase, with international revenue at 840 million yuan representing a record 36% of total. New business segments contributed 48.5% of total revenue, signaling successful business mix evolution from legacy cold chain hardware to integrated life science scenarios. The company is executing a three-year '543' strategic plan targeting over 50% overseas revenue, 30% AI-related revenue, and over 40% revenue from acquired businesses by 2028, supported by active geographic expansion (Q1 2026 growth of 50%+ in Germany, Australia, and Canada and over 100% in Eastern Europe, South Asia, and Brazil), ongoing product launches (HAB80-60KA/60KB, DWL368BPST, Super Energy series, AutoLab Mind, Hailinglong Lingyan LLM), and inorganic moves including the December 2023 acquisition of Guangzhou Kangsheng Biotechnology and EU MDR certification for the Plasma Apheresis System XJ-III.

Qingdao Haier Biomedical firmographics

Firmographics
Name
Qingdao Haier Biomedical
Legal name
青岛海尔生物医疗股份有限公司
Website
https://haierbiomedical.com
Company type
Public
Founded year
2005
Operating status
Operating
Headcount range
11–50 employees
Short description
Qingdao Haier Biomedical (SSE: 688139) designs and sells ultra-low temperature storage systems, automated biobank solutions, IoT-enabled cold chain equipment, and AI-integrated life science laboratory products. The company serves pharmaceutical companies, hospitals, research institutes, biobanks, and public health agencies across 160 countries.
Ownership category
akta.pro rank

Qingdao Haier Biomedical industry classification

Industry
Product category
Life Science Laboratory Equipment
NAICS
Air-Conditioning and Warm Air Heating Equipment and Commercial and Industrial Refrigeration Equipment Manufacturing (333415), Medical Equipment and Supplies Manufacturing (3391), Analytical Laboratory Instrument Manufacturing (334516), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
SIC
Air-Cond & Warm Air Heatg Equip & Comm & Indl Refrig Equip (3585), Refrigeration & Service Industry Machinery (3580), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAGAIAJ
Sample Preparation, Storage & Cryogenics (Freezers, Cryovials, Cryostats)
SECONDARYHLAGAMAG
Cold Chain Monitoring, Sensors & Control Towers (IoT, data loggers)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Supply Chain, Logistics & Cold Chain for Life Sciences

Keywords

  • Biomedical cold storage
  • Ultra-low temperature freezers
  • Automated biobank systems
  • IoT cold chain monitoring
  • Life science laboratory equipment

Where Qingdao Haier Biomedical is headquartered

Location

Headquarters

HQ city
Qingdao
HQ country
China
HQ region
Asia

Offices5 records

Markets served

Qingdao Haier Biomedical business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Operations, Personnel, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

  1. Life Science Laboratory Equipment Sales: Haier Biomedical generates revenue primarily through the sale of life science laboratory equipment including ultra-low temperature freezers, automated sample storage systems, biobank solutions, blood management systems, and pharmaceutical storage solutions. The company achieved full-year 2025 revenue of 2.33 billion yuan (USD 340.77 million) with international revenue of 840 million yuan representing 36% of total revenue.
  2. AI-Powered Applications and Solutions: AI-powered applications and software solutions contributed 15% of total revenue in 2025, up 2.5 percentage points from 2024, including automated biobank management, intelligent blood management, and AI-integrated medical products. New business segments contributed 48.5% of total revenue.
  3. Sustainability and Digital Transformation Services: The company provides digital, global, and platform-oriented transformation services aligned with its LIFE sustainability framework, positioning itself as an integrated life science tools and intelligent productivity platform provider rather than a pure hardware vendor.

Go-to-market motion3 records

Distribution channels5 records

Marketing channels5 records

Qingdao Haier Biomedical product offering

Product offering

Core offering

Qingdao Haier Biomedical designs, manufactures, and sells ultra-low temperature storage systems, automated biobank solutions, smart hospital medication and blood management systems, and AI-integrated medical products for pharmaceutical companies, research institutions, hospitals, blood stations, and public health agencies. The company also provides reagents, consumables, biosafety equipment, scientific instruments, and digital transformation services, and is transitioning from hardware supplier to integrated life science tools and intelligent productivity platform provider through its IoT and AI capabilities.

Product overview

Qingdao Haier Biomedical (海尔生物医疗, stock code 688139.SH) is a life science and medical innovation company offering a comprehensive platform-plus-modules product architecture. The portfolio centers on ultra-low temperature storage systems (HAB80-60KA/60KB automated storage, DWL368BPST compact freezer, Ultra Energy series, Super Energy series) complemented by an extensive ecosystem of laboratory equipment including pre-processing systems, biosafety equipment, scientific instruments, and smart hospital solutions. The company is undergoing strategic transformation from hardware supplier to integrated life science tools provider, with AI+ capabilities now integrated across product lines through solutions like the Hailinglong Lingyan Large Model (sample library AI), AutoLab Mind platform, AI+ automated cell culture solutions, cytotoxic drug dispensing robots, and intelligent blood management systems. Core solutions span biobank management, smart vaccination, digital hospital medication management, and laboratory automation.

Differentiator

Problem solved

Functional benefit

Brands

  • 盈康一生 (Yingkang Yisheng): Related brand/platform under the Haier healthcare ecosystem umbrella.

Products and services

  • HAB80-60KA/60KB Automated Ultra-Low Temperature Sample Storage System Automated ultra-low temperature sample storage system for biobank applications at -80°C, with AI-powered monitoring, scalable modular architecture for 50,000 to 200,000+ samples, and low-carbon design targeting European biobank customers.
  • DWL368BPST Compact Ultra-Low Temperature Freezer Space-efficient ultra-low temperature freezer engineered for Japanese laboratories, featuring 26% lower energy consumption, ±2°C temperature uniformity, and 45% faster temperature recovery compared to conventional models.
  • Plasma Apheresis System XJ-III Plasma apheresis system with EU MDR certification for blood component collection and processing in clinical settings across the European Union.
  • Hailer Vaccine Smart Safety Solution (海乐苗智慧安全接种)

Quantifiable outcome

  • 26% lower energy consumption and 45% faster temperature recovery compared to conventional models for DWL368BPST ultra-low temperature freezer
  • +6 more outcomes

Companies that use Qingdao Haier Biomedical

Customer profile

Named customers13 records

Segments5 records

Ideal customer profiles4 records

Qingdao Haier Biomedical technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature5 records

Qingdao Haier Biomedical partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core.

  • Università degli Studi di PadovacoreStrategic or Co-development Partner · 25 June 2026Deep academic partnership with Università degli Studi di Padova as part of Haier Biomedical's strategy to deepen localization investments and build academic partnerships supporting the 'In Europe, for Europe' localization strategy and European market development.
  • Alibaba Cloud (阿里云)coreTechnology or Integration · 10 April 2026AI for Science strategic ecosystem partnership for cloud computing and AI infrastructure support, announced at the 93rd CMEF as part of Haier Biomedical's AI+ innovation strategy ecosystem co-creation.
  • Zhongke Zidong Taichu (中科紫东太初)coreTechnology or Integration · 10 April 2026AI for Science strategic ecosystem partnership for AI model development, announced at the 93rd CMEF as part of Haier Biomedical's AI+ innovation strategy ecosystem co-creation.
  • Aobo Robotics (遨博(北京)智能)coreTechnology or Integration · 10 April 2026AI for Science strategic ecosystem partnership for robotics integration, announced at the 93rd CMEF as part of Haier Biomedical's AI+ innovation strategy ecosystem co-creation.
  • Shandong University of Science and Technology (山东科技大学)coreStrategic or Co-development Partner · 10 April 2026AI for Science strategic ecosystem partnership for research collaboration and talent development, announced at the 93rd CMEF as part of Haier Biomedical's AI+ innovation strategy ecosystem co-creation.
  • China Information Industry Association Embodied AI Specialized Committee (中国信息协会具身智能专委会)coreStrategic or Co-development Partner · 10 April 2026AI for Science strategic ecosystem partnership for embodied AI standards and industry collaboration, announced at the 93rd CMEF as part of Haier Biomedical's AI+ innovation strategy ecosystem co-creation.
  • 37 European Regional Partners (23 Countries)coreChannel Partner/ Reseller/ Distributor · 11 March 2026European Partner Summit in Rome with 37 regional partners from 23 European countries, outlining the long-term European commitment and unveiling expanded laboratory solutions portfolio under the 'In Europe, for Europe' localization strategy. Rollout of automated biobank solutions and intelligent blood management systems through these channel partners.
  • GAVI, the Vaccine AlliancecoreStrategic or Co-development Partner · 1 January 2025Partnership with GAVI for global immunization support and health equity, documented in the 2025 sustainability report under the LIFE framework aligned with UN's 17 Sustainable Development Goals. Includes charitable donations of 1.406 million yuan.

Scale indicators16 records

Recent moves7 records

Expansion highlights6 records

Qingdao Haier Biomedical competitors and assessment

Company assessment

Direct peers

  • Helmer Scientific: US-based manufacturer of medical-grade cold storage, particularly blood bank refrigerators and plasma freezers. Direct overlap with Haier Biomedical's hospital, blood station, and clinical laboratory segments in North America.
  • PHC Holdings (formerly Panasonic Healthcare): Direct competitor in biomedical cold storage, including ultra-low temperature freezers and pharmaceutical-grade refrigeration under PHCbi. Operates globally with strong European and US presence, making it a primary head-to-head rival for Haier Biomedical's ULT and biobank systems.
  • Stirling Ultracold: US manufacturer of ultra-low temperature freezers with a focus on energy-efficient Stirling engine technology. Competes directly in the ULT freezer category, including for biobank and pharmaceutical storage applications.
  • Azenta Life Sciences (formerly Brooks Life Sciences): Provider of sample storage, automated biobanking, and cold chain solutions. Recently combined with B Medical Systems, making it a direct competitor in automated sample management and biorepository solutions where Haier Biomedical's HAB80-60KA/60KB platform competes.
  • Eppendorf: German lab equipment manufacturer with overlapping product lines in temperature-controlled storage, sample handling, and cell culture. Strong in European pharmaceutical and academic research markets where Haier Biomedical is actively expanding.
  • B Medical Systems: Specializes in medical cold chain including vaccine cold boxes, plasma freezers, and ULT storage. Recently combined with Azenta's life sciences business, directly competing with Haier Biomedical in blood bank, vaccine, and biobank cold chain.

Regional players

  • Labconco: US-based manufacturer of laboratory equipment including biosafety cabinets and cold storage. Has partial product overlap with Haier Biomedical's biosafety and laboratory equipment lines, primarily in the North American market.

Broad incumbents

  • Thermo Fisher Scientific: Global leader in life sciences with a deep portfolio including ultra-low temperature freezers, sample storage, and biobank solutions. Competes with Haier Biomedical across pharma and research customers worldwide but at vastly greater scale and with broader adjacent offerings.
  • Mindray: Shenzhen-based Chinese medical device major with extensive hospital and IVD product lines. Competes with Haier Biomedical in the smart hospital medication management and biomedical equipment segments within China and emerging markets.

Others

  • Haier Smart Home: Sister listed entity under the same Haier Group parent, focused on consumer appliances. While not a direct competitor, it provides relevant peer context on the parent conglomerate's global brand and distribution scale leveraged by Haier Biomedical.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Qingdao Haier Biomedical compliance and trust

Trust signal

Compliance2 records

Qingdao Haier Biomedical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Qingdao Haier Biomedical leadership team

Management profile

Number of profiles

Qingdao Haier Biomedical subsidiaries and ownership

Company hierarchy

Subsidiaries5 records

Qingdao Haier Biomedical funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Qingdao Haier Biomedical M&A and investment

M&A and investment

M&A1 record

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Qingdao Haier Biomedical

What does Qingdao Haier Biomedical do?

Qingdao Haier Biomedical designs, manufactures, and sells ultra-low temperature storage systems, automated biobank solutions, smart hospital medication and blood management systems, and AI-integrated medical products for pharmaceutical companies, research institutions, hospitals, blood stations, and public health agencies. The company also provides reagents, consumables, biosafety equipment, scientific instruments, and digital transformation services, and is transitioning from hardware supplier to integrated life science tools and intelligent productivity platform provider through its IoT and AI capabilities.

Is Qingdao Haier Biomedical a public or private company?

Qingdao Haier Biomedical is a public company. It is classified as public and is currently operating.

When was Qingdao Haier Biomedical founded?

Qingdao Haier Biomedical was founded in 2005. It employs 11 to 50 people.

Where is Qingdao Haier Biomedical based?

Qingdao Haier Biomedical is headquartered in Qingdao, China, in the Asia region.

How does Qingdao Haier Biomedical make money?

Three revenue lines are on record. Life Science Laboratory Equipment Sales are the primary driver. The others are AI-Powered Applications and Solutions and sustainability and Digital Transformation Services.

Who are Qingdao Haier Biomedical's main competitors?

Direct peers on record are Helmer Scientific, PHC Holdings (formerly Panasonic Healthcare), Stirling Ultracold, Azenta Life Sciences (formerly Brooks Life Sciences), Eppendorf and B Medical Systems. Labconco is listed as a regional player. Broad incumbents are Thermo Fisher Scientific and Mindray. Haier Smart Home is listed as an others.

Does Qingdao Haier Biomedical have an API?

No public API is recorded for Qingdao Haier Biomedical.

What industry is Qingdao Haier Biomedical in?

Qingdao Haier Biomedical's product category is Life Science Laboratory Equipment. Its primary akta.pro industry code is HLAGAIAJ, Sample Preparation, Storage & Cryogenics (Freezers, Cryovials, Cryostats), with a secondary code of HLAGAMAG, Cold Chain Monitoring, Sensors & Control Towers (IoT, data loggers). Its NAICS code is 333415 and its SIC code is 3585.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireHaier Biomedical präsentiert seine Fachkenntnisse im Blutmanagement und in der pharmazeutischen Kühllagerung auf der AABB und der ISPE 2026Haier Biomedical presented blood management and pharmaceutical cold storage solutions at the AABB and ISPE conferences in October 2026. The company also led a proposal for an IEC standard on medical refrigeration equipment, citing over 70 FDA approvals and 36 ENERGY STAR models.AktienHaier Biomedical präsentiert seine Fachkenntnisse im Blutmanagement und in der pharmazeutischen Kühllagerung auf der AABB und der ISPE 2026Haier Biomedical presented blood management and pharmaceutical cold storage solutions at the AABB and ISPE 2026 conferences in October. The company also led a proposal for an IEC standard on medical refrigeration equipment. Its solutions are used at institutions like Stanford and Mayo Clinic, with over 70 FDA approvals and 36 ENERGY STAR models.PR NewswireHaier Biomedical apporte son expertise en matière de gestion du sang et de stockage frigorifique pharmaceutique lors de la réunion de l'AABB et de l'ISPE 2026Haier Biomedical presented blood management and pharmaceutical cold storage solutions at the AABB and ISPE 2026 meetings in October. The company also announced a CEI-approved project to develop the first international standard for medical cold storage and freezing equipment. Its solutions are deployed at institutions like Stanford and Mayo Clinic.MoomooHaier Biomedical Aporta Su Experiencia AABB E ISPE 2026Haier Biomedical presented blood management and cold-chain storage solutions at AABB and ISPE 2026 in Atlanta and National Harbor. The company also led an IEC proposal for the first international standard for medical cold storage facilities. Its solutions are used at institutions like Stanford and Mayo Clinic, with over 70 FDA approvals and 12 AABB certifications.PR NewswireHaier Biomedical aporta su experiencia AABB e ISPE 2026Haier Biomedical presented blood management and pharmaceutical cold storage solutions at AABB and ISPE 2026 in Atlanta and National Harbor, Md. The company also led an IEC proposal for the first international standard for medical cold storage facilities. Its solutions are used at institutions like Stanford and Mayo Clinic, with over 70 FDA approvals and 12 AABB certifications.PR Newswire APACHaier Biomedical Brings Blood Management and Pharmaceutical Cold Storage Expertise to AABB and ISPE 2026Haier Biomedical showcased blood management and pharmaceutical cold storage solutions at the 2026 AABB and ISPE meetings in October. The company also led a proposal for an IEC standard on medical cold storage facilities. Its solutions are deployed at institutions like Stanford and Mayo Clinic, with over 70 FDA approvals and 12 AABB certifications.YahooHaier Biomedical Brings Blood Management and Pharmaceutical Cold Storage Expertise to AABB and ISPE 2026Haier Biomedical showcased blood management and pharmaceutical cold storage solutions at the 2026 AABB and ISPE meetings in October. The company led a proposal for an IEC standard on medical cold storage facilities and cites over 70 FDA approvals and 36 ENERGY STAR-certified models.MoomooHaier Biomedical Brings Blood Management and Pharmaceutical Cold Storage Expertise to AABB and ISPE 2026Haier Biomedical showcased blood management and pharmaceutical cold storage solutions at the 2026 AABB and ISPE meetings in Atlanta and National Harbor. The company led an IEC project to develop the first international standard for medical cold storage facilities. Its solutions are deployed at institutions like Stanford and Mayo Clinic, with over 70 FDA approvals and 12 AABB certifications.NewswireHaier Biomedical Brings Blood Management and Pharmaceutical Cold Storage Expertise to AABB and ISPE 2026Haier Biomedical showcased blood management and pharmaceutical cold storage solutions at the 2026 AABB and ISPE meetings in October. The company led an IEC project to develop the first international standard for medical cold storage facilities. Its solutions are deployed at institutions like Stanford and Mayo Clinic, with over 70 FDA approvals and 36 ENERGY STAR-certified models.PR NewswireHaier Biomedical Brings Blood Management and Pharmaceutical Cold Storage Expertise to AABB and ISPE 2026Haier Biomedical showcased blood management and pharmaceutical cold storage solutions at the 2026 AABB and ISPE meetings in October. The company led a proposal for an IEC standard covering performance requirements for medical cold storage facilities. It also highlighted its U.S. presence, including deployments at Stanford, Mayo Clinic, and Texas Children's Hospital.